8-K
filed June 10, 2026, 4:15 PM ET
ticker SNDX
CIK 0001395937
other
confidence high
sentiment neutral
materiality 0.25
Syndax shareholders approve 2026 equity plans; 7.2M new shares reserved
Syndax Pharmaceuticals Inc
- Stockholders approved 2026 Equity Incentive Plan authorizing 7,200,000 new shares plus returning shares from prior plan.
- Stockholders also approved 2026 Employee Stock Purchase Plan as successor to 2015 ESPP; no rollover of prior shares.
- Proposal 4 (2026 Plan) passed with 33,333,263 for vs. 25,392,051 against; Proposal 5 (ESPP) passed with 58,661,941 for.
- All director nominees elected and advisory vote on executive compensation passed; ratification of auditor approved.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Syndax Pharmaceuticals Inc shareholders approved Advisory vote on executive compensation at the 2026-06-10 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2026-06-10
Exact text from the filing
For Against Abstain Broker Non-Votes 55,688,039 2,985,350 89,474 8,034,588
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Syndax Pharmaceuticals Inc shareholders approved Election of directors at the 2026-06-10 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-06-10
Exact text from the filing
Pierre Legault 37,294,888 21,467,975 8,034,588 Michael A. Metzger 58,113,110 649,753 8,034,588
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Syndax Pharmaceuticals Inc shareholders approved Ratification of selection of independent registered public accounting firm at the 2026-06-10 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-06-10
Exact text from the filing
For Against Abstain Broker Non-Votes 66,603,912 162,947 30,592 —
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Syndax Pharmaceuticals Inc shareholders approved Approval of the 2026 Plan at the 2026-06-10 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2026-06-10
Exact text from the filing
For Against Abstain Broker Non-Votes 33,333,263 25,392,051 37,549 8,034,588
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Syndax Pharmaceuticals Inc shareholders approved Approval of the 2026 ESPP at the 2026-06-10 meeting.
- Outcome
- passed
- Meeting
- 2026-06-10
Exact text from the filing
For Against Abstain Broker Non-Votes 58,661,941 74,047 26,875 8,034,588
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.